540726 TTFL

Trident Texofab Share Price

₹173.00 +1.05 (0.61%)

04 Mar, 2025 02:39

SIP TrendupStart SIP in TTFL

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month + 11%
  • Over 3 Month + 40.76%
  • Over 6 Month + 285.99%
  • Over 1 Year + 201.87%
SIP Lightning

Smart Investing Starts Here Start SIP with Trident Texofab for Steady Growth!

Invest Now

Trident Texofab Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Trident Texofab Financials

Trident Texofab Technicals

EMA & SMA

Current Price
₹173.00
+ 1.05 (0.61%)
pointer
  • stock-down_img
  • Bearish Moving Average 5
  • stock-up_img
  • Bullish Moving Average 11
  • 20 Day
  • ₹172.03
  • 50 Day
  • ₹162.47
  • 100 Day
  • ₹140.66
  • 200 Day
  • ₹112.25

Resistance and Support

171.27 Pivot Speed
  • R3 192.08
  • R2 184.92
  • R1 178.43
  • S1 164.78
  • S2 157.62
  • S3 151.13

What's your outlook on Trident Texofab?

You can only vote for once

Trident Texofab Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-03 Quarterly Results
2024-10-23 Others
2024-10-12 Quarterly Results
2024-07-18 Quarterly Results (Revised) issue in the ratio of 14:10 of Rs. 10/-
2024-05-25 Audited Results (Revised) issue in the ratio of 14:10 of Rs. 10/-

Trident Texofab F&O

Trident Texofab Shareholding Pattern

No data available.

About Trident Texofab

  • NSE Symbol
  • TTFL
  • BSE Symbol
  • 540726
  • ISIN
  • INE071Y01013

Similar Stocks to Trident Texofab

Trident Texofab FAQs

Trident Texofab share price is ₹173 As on 04 March, 2025 | 02:25

The Market Cap of Trident Texofab is ₹177.8 Cr As on 04 March, 2025 | 02:25

The P/E ratio of Trident Texofab is 93.7 As on 04 March, 2025 | 02:25

The PB ratio of Trident Texofab is 10.8 As on 04 March, 2025 | 02:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23